OA10.05 An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)
J.H. Cho,
Jong‐Mu Sun,
S. Lee,
Jin Seok Ahn,
K. Park,
K.U. Park,
Eun Joo Kang,
Yoon Hee Choi,
Kyae Hyung Kim,
Ho Jung An,
Journal of Thoracic Oncology · 2018 · 16 citations · 0 references